Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/LONGBOARD-PHARMACEUTICALS-120177740/news/Longboard-Pharmaceuticals-gibt-positive-Topline-Daten-einer-klinischen-Phase-1-Studie-zur-Bewertung-42486764/?utm_source=whatsapp&utm_medium=social&utm_campaign=share